Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma

Clinical trial NCT05100082 · COMPLETED

Trial details

NCT number: NCT05100082
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatocellular Cancer

Start date: 2021-11-17
Primary completion: 2025-11-30
Enrollment: 263

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.